Procoagulant CaCO3-embedded embolic microspheres can potentiate transcatheter arterial embolization of hepatocellular carcinoma
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Hepatocellular Carcinoma Treatment and Prognosis · Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review
2. Goals and targets for personalized therapy for HCC10.1007/s12072-018-9919-1 ↗
3. Surgical and locoregional therapy of HCC: TACE10.1159/000367739 ↗
4. Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: the SPACE trial10.1016/j.jhep.2016.01.012 ↗
5. Hepatocellular carcinoma10.1016/S0140-6736(11)61347-0 ↗
6. Permanent and peripheral embolization: temperature-sensitive p (N-Isopropylacrylamide-co-butyl methylacrylate) nanogel as a novel blood-vessel-embolic material in the interventional therapy of liver tumors10.1002/adfm.201002510 ↗
7. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design10.1016/j.jhep.2012.01.008 ↗
8. Chemoembolization of hepatocellular carcinoma with extrahepatic collateral blood supply: anatomic and technical considerations10.1148/rg.2017160122 ↗
9. Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces10.1007/s00270-004-0238-7 ↗
10. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents10.1097/01.RVI.0000182160.26798.A2 ↗
11. Transarterial embolization modulates the immune response within target and nontarget hepatocellular carcinomas in a rat model10.1148/radiol.211028 ↗
12. A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis10.7554/eLife.15691 ↗
13. Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles10.1038/s41551-020-0573-2 ↗
14. Tumor vascular infarction: prospects and challenges10.1007/s12185-016-2171-3 ↗
15. Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience, Blood
16. Therapeutic strategies for thrombosis: new targets and approaches10.1038/s41573-020-0061-0 ↗
17. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature10.1126/science.275.5299.547 ↗
18. Targeting tissue factor to tumor vasculature to induce tumor infarction10.3390/cancers13112841 ↗
19. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo10.1038/nbt.4071 ↗
20. A biomimetic platelet based on assembling peptides initiates artificial coagulation
21. CaCO 3 nanoparticles pH-sensitively induce blood coagulation as a potential strategy for starving tumor therapy10.1039/C9TB02684C ↗
22. Fatal complication after thrombin injection for post-catheterization femoral pseudoaneurysm10.1055/s-0030-1270837 ↗
23. Progress of gelatin-based microspheres (GMSs) as delivery vehicles of drug and cell10.1016/j.msec.2021.111949 ↗
24. Current status of embolic agents for liver tumor embolization10.1007/s10147-012-0445-1 ↗
25. CaCO3 nanoparticles as an ultra-sensitive tumor-pH-responsive nanoplatform enabling real-time drug release monitoring and cancer combination therapy10.1016/j.biomaterials.2016.09.025 ↗
26. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis10.1111/jth.12455 ↗
27. Overview of the coagulation system10.4103/0019-5049.144643 ↗
28. The acidic tumor microenvironment as a driver of cancer10.1146/annurev-physiol-021119-034627 ↗
29. Neutralization of tumor acidity improves antitumor responses to immunotherapy10.1158/0008-5472.CAN-15-1743 ↗
30. Fabrication of Fe3O4@ PVA microspheres by one-step electrospray for magnetic resonance imaging during transcatheter arterial embolization10.1016/j.actbio.2021.07.006 ↗
31. Tumor microenvironment modulating CaCO3-based colloidosomal microreactors can generally reinforce cancer immunotherapy
32. CaCO3 based proton nanosponge to potentiate immune checkpoint blockade therapy by synergistically reversing tumor immunosuppression10.1016/j.cej.2023.142206 ↗
33. Percutaneous liquid ablation agent for tumor treatment and drug delivery10.1126/scitranslmed.abe3889 ↗